Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Systematic Review

Published on 02 May 2023

A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications

in Drugs Outcomes Research and Policies

Yuting Shan
Lee Cheung
Yuqi Zhou
Yingbo Huang
R. Stephanie Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1096366

7,530 views
10 citations

Original Research

Published on 27 Apr 2023

When we shouldn’t borrow information from an existing network of trials for planning a new trial

in Drugs Outcomes Research and Policies

Fangshu Ye
Chong Wang
Annette M. O’Connor

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157708

1,439 views
1 citation

Original Research

Published on 27 Apr 2023

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)

in Drugs Outcomes Research and Policies

François R. Girardin
Anna Nicolet
Oriol Bestard
Carmen Lefaucheur
Klemens Budde
Fabian Halleck
Sophie Brouard
Magali Giral
Pierre-Antoine Gourraud
Béatrice Horcholle

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1040584

3,651 views
2 citations

Original Research

Published on 21 Apr 2023

Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends

in Drugs Outcomes Research and Policies

Elif Car
Arnold G. Vulto
Mark Van Houdenhoven
Isabelle Huys
Steven Simoens

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1151764

9,591 views
23 citations

Original Research

Published on 20 Apr 2023

Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study

in Drugs Outcomes Research and Policies

Geok Ying Chun
Nurul Ain Mohd Tahir
Farida Islahudin
Veena Selvaratnam
Shu Chuen Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1128887

18,041 views

Systematic Review

Published on 14 Apr 2023

Health-related quality of life in Her2-positive early breast cancer woman using trastuzumab: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Sudewi Mukaromah Khoirunnisa
Fithria Dyah Ayu Suryanegara
Didik Setiawan
Maarten Jacobus Postma

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090326

3,624 views
4 citations

Original Research

Published on 13 Apr 2023

Introduction of managed entry agreements in Korea: Problem, policy, and politics

in Drugs Outcomes Research and Policies

Hyungmin Kim
Brian Godman
Hye-Young Kwon
Song Hee Hong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.999220

9,306 views
4 citations

Editorial

Published on 11 Apr 2023

Editorial: Advances in drug-induced diseases

in Drugs Outcomes Research and Policies

Yao Liu
Jia-bo Wang
Linan Zeng
Maxine Gossell-Williams
Patricia Moriel
Miao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1193099

4,960 views
1 citation

Original Research

Published on 07 Apr 2023

Nurses in China lack knowledge of inhaler devices: A cross-sectional study

in Drugs Outcomes Research and Policies

Ning Xie
Zheng Zheng
Qilian Yang
Man Li
Xiaofen Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1152069

3,250 views
4 citations

General Commentary

Published on 06 Apr 2023

Commentary: Quantile treatment effect of zinc lozenges on common cold duration: A novel approach to analyze the effect of treatment on illness duration

in Drugs Outcomes Research and Policies

Jonas Moss

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1152305

1,548 views
1 citation

Editorial

Published on 05 Apr 2023

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)

in Drugs Outcomes Research and Policies

Elena Ramírez
Miguel González-Muñoz
Chanda Kulkarni
Francisco J. De Abajo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1175039

1,567 views
1 citation

Systematic Review

Published on 05 Apr 2023

Clinical, economic and humanistic outcomes of medication therapy management services: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Zhi-Jie Deng
Lin Gui
Jing Chen
Shun-Shun Peng
Yu-Feng Ding
An-Hua Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1143444

8,077 views
13 citations

Original Research

Published on 04 Apr 2023

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database

in Drugs Outcomes Research and Policies

Dongxuan Li
Jinghui Gou
Jun Zhu
Tongyan Zhang
Feng Liu
Daojun Zhang
Liyang Dai
Wenjun Li
Qinglong Liu
Chunmeng Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1117391

6,710 views
17 citations

Systematic Review

Published on 28 Mar 2023

Efficacy and tolerability of perampanel in patients with seizures in real-world clinical practice: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Liyan Hou
Jingjing Yang
Xuan Zhang
Na Li
Sheng Li
Lei Zhang
Jie Zhao
Qingshan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139514

3,921 views
3 citations

Original Research

Published on 27 Mar 2023

Utilization of psychotropic medicines in Romania during 1998–2018

in Drugs Outcomes Research and Policies

Irina Iaru
Camelia Bucsa
Andreea Farcas
Cristina Pop
Anamaria Cristina
Sebastian Armean
Irina Brumboiu
Oliviu Vostinaru
Cristina Mogosan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157231

4,446 views
3 citations

Clinical Trial

Published on 24 Mar 2023

Analysis of patient medication compliance and quality of life of physician-pharmacist collaborative clinics for T2DM management in primary healthcare in China: A mixed-methods study

in Drugs Outcomes Research and Policies

Jie Xiao
Qing Wang
Shenglan Tan
Lei Chen
Bingjie Tang
Shuting Huang
Yangang Zhou
Ping Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1098207

4,183 views
6 citations